Back to BARCLAYS PLC BARCLAYS PLC

LIMNLIMN
3 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in LIMINATUS PHARMA INC.

Yes. Barclays holds 4,290 shares of LIMN (Liminatus Pharma), worth $474, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$474

Current Shares

4,290

Total Value Change

-$1,578

Total Shares Change

+4,106

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
4,290
-
$4740.0%$5.50
17
2025-Q3
Exited
0
-100.0%
$00.0%$83.50
0
2025-Q2
New
184
-
$2,0520.0%$557.50
17

Other major holders of LIMN: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used